About Reveal Biosciences
Reveal Biosciences is a company based in San Diego (United States) founded in 2012 was acquired by CellCarta in May 2021. Reveal Biosciences offers products and services including Biomarker Solutions, CellEngine® Software, Genomic Services, and Histopathology Services. Reveal Biosciences operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reveal Biosciences
Reveal Biosciences offers a comprehensive portfolio of products and services, including Biomarker Solutions, CellEngine® Software, Genomic Services, and Histopathology Services.
Offers immune monitoring and proteomics for drug development research.
Cytometry software for comprehensive data analysis in clinical studies.
Provides digital PCR and RNA sequencing for biomarker discovery.
Delivers digital pathology and IHC for therapeutic expertise.
People of Reveal Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Reveal Biosciences
Investors in Reveal Biosciences
Reveal Biosciences has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include CellCarta, GNI Group and PP Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Education startups are funded and mentored by Intel-backed accelerator.
|
Locked | Locked | Locked | |
|
Multinational company engaged in the research, development, & manufacturing of pharmaceutical drugs
|
Locked | Locked | Locked |
Investor details for Reveal Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reveal Biosciences
Investment portfolio details for Reveal Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reveal Biosciences
Detailed financials for Reveal Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reveal Biosciences Comparisons
Peer comparison for Reveal Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reveal Biosciences
Reveal Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of Reveal Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reveal Biosciences
Complete news archive for Reveal Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reveal Biosciences
Reveal Biosciences was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Reveal Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Reveal Biosciences was founded in 2012 in San Diego, United States, within the biotechnology sector. Services in pathology are delivered to researchers, focusing on histology, immunochemistry, in situ hybridization, immunofluorescence, multiplexed diagnostics, and next-generation pathology. Proprietary software for image analysis is applied to whole slide images, with quantified data supplied in CSV or Excel formats. A partnership with Affymetrix has been sustained since December 2015.
Reveal Biosciences's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Reveal Biosciences offers Biomarker Solutions, CellEngine® Software, Genomic Services, and Histopathology Services.
Reveal Biosciences has 4 investors. Key investors include CellCarta, GNI Group, PP Capital, and Intel Education Accelerator.